Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence

GBM patients receiving PDT treatment (50 cases，surgery combined with photodynamic therapy) and traditional treatment (50 cases，traditional surgery) in our hospital and partner hospitals were collected. The prognosis was analyzed by comparing with the control group from multiple perspectives such as image evaluation, imaging effect, Karnofsky score, median survival time and survival rate.

NCT Number	NCT06939400
Lead Sponsor	Zhejiang Provincial People's Hospital Collaborators: The Second Affiliated Hospital of Harbin Medical University
Conditions	Glioblastoma Multiforme (GBM)
Enrollment	100 participants
Start Date	2025-06-01
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-22